Treatment of chronically depressed patients: A multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depressions versus usual secondary care

Department of Psychiatry and Institute for Research in Extramural Medicine, VU University Medical Center and Academic Outpatient Clinic for Affective Disorders, Stichting GGZBuitenamstel-de Geestgronden, The Netherlands.
BMC Psychiatry (Impact Factor: 2.21). 02/2008; 8(1):18. DOI: 10.1186/1471-244X-8-18
Source: PubMed


'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) is a form of psychotherapy specifically developed for patients with chronic depression. In a study in the U.S., remarkable favorable effects of CBASP have been demonstrated. However, no other studies have as yet replicated these findings and CBASP has not been tested outside the United States. This protocol describes a randomized controlled trial on the effectiveness of CBASP in the Netherlands.
The purpose of the present paper is to report the study protocol of a multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depression in the Netherlands. In this study, CBASP in combination with medication, will be tested versus usual secondary care in combination with medication. The aim is to recruit 160 patients from three mental health care organizations. Depressive symptoms will be assessed at baseline, after 8 weeks, 16 weeks, 32 weeks and 52 weeks, using the 28-item Inventory for Depressive Symptomatology (IDS). Effect modification by co morbid anxiety, alcohol consumption, general and social functioning and working alliance will be tested. GEE analyses of covariance, controlling for baseline value and center will be used to estimate the overall treatment effectiveness (difference in IDS score) at post-treatment and follow up. The primary analysis will be by 'intention to treat' using double sided tests. An economic analysis will compare the two groups in terms of mean costs and cost-effectiveness from a societal perspective.
The study will provide an answer to the question whether the favorable effects of CBASP can be replicated outside the US.
The Dutch Cochrane Center, NTR1090.

Download full-text


Available from: Digna JF van Schaik,
  • Source
    • "Chronicity of depressive and anxiety disorders was assessed by the life chart (Wiersma et al., 2008) which determines through a calendar method the chronicity of depressive and anxiety symptoms in the previous four years. As done before (Wiersma et al., 2008), a dichotomous chronicity variable was constructed categorized as at least 24 months of reported depressive or anxiety symptoms in the previous four years or not. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Depressive and anxiety disorders affect work functioning and cause high labour costs. To examine and compare psychopathological characteristics of depressive and anxiety disorders in their effect on work functioning. In 1876 working participants of the Netherlands Study of Depression and Anxiety (NESDA) associations of presence, severity, comorbidity, duration and type of DSM-IV anxiety and depressive disorders with both absenteeism (<2 weeks and >2 weeks) and work performance (reduced and impaired) were assessed. People with current depressive disorders had 7.10 times greater odds for the risk of >2 weeks work-absence and 5.67 greater odds for the risk of impaired work performance, while persons with current anxiety disorders had 1.84 and 2.13 greater odds for the risk of >2 weeks absence and impaired work performance, respectively. Even when persons were recovered from depressive and anxiety disorders, they still had a higher risk of poor work functioning. Persons with comorbidity, chronic depressive disorder, a generalized anxiety disorder, and more severity of both anxiety and depressive disorder had higher odds for the risk of absenteeism and decreased work performance. Anxiety disorders have significant negative impact on work functioning, although smaller than the effect of depressive disorders. Comorbidity, severity, type and duration of the disorder, differentiate the risk of poor work functioning.
    Journal of Affective Disorders 02/2010; 125(1-3):198-206. DOI:10.1016/j.jad.2010.01.072 · 3.38 Impact Factor

  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronische depressies hebben de afgelopen jaren steeds meer aandacht gekregen als specifieke categorie binnen de heterogene groep van depressieve stoornissen. Niet alleen vanuit epidemiologisch, maar ook vanuit behandelperspectief. Er zijn aanwijzingen dat Cognitive Behavioral Analysis System of Psychotherapy (CBASP) voor patiënten met een chronisch verlopende depressie meerwaarde heeft boven de gangbare psychotherapieën1.
    04/2013; 5(2). DOI:10.1007/s13170-013-0021-z
Show more